F-Star collaboration

By CT Team | May 31, 2018

Please follow and like us:

As announced today (May 31), Confluence Tax is delighted to have assisted F-star on the acquisition of the asset-centric vehicle F-Star Gamma by Denali Therapeutics, leveraging F-star’s Modular Antibody Technology™ beyond immuno-oncology. Read the full press release here.

Tagged Asset centric, Denali Therapeutics, F-star, F-star Gamma

About CT Team

The tax advisors to biotechnology and technology companies

View all posts by CT Team →